Sanofi’s tolebrutinib fails 2 of trio of phase 3 MS trials, but pharma still plans FDA filing 0 01.09.2024 22:50 Fiercebiotech.com Sanofi’s tolebrutinib fails 2 of trio of phase 3 MS trials, but pharma still plans FDA filing jwaldron Sun, 09/01/2024 - 15:50
